QQQ   427.60 (+0.41%)
AAPL   168.18 (+0.11%)
MSFT   410.91 (-0.23%)
META   510.58 (+3.32%)
GOOGL   156.18 (+0.46%)
AMZN   182.28 (+0.55%)
TSLA   151.05 (-2.83%)
NVDA   854.23 (+1.65%)
AMD   156.56 (+1.65%)
NIO   4.04 (+3.32%)
BABA   69.52 (+1.02%)
T   16.17 (+0.31%)
F   12.13 (+0.75%)
MU   115.39 (-0.81%)
GE   156.99 (+0.85%)
CGC   7.79 (+20.03%)
DIS   114.00 (+0.94%)
AMC   2.88 (-3.36%)
PFE   25.37 (-0.20%)
PYPL   63.04 (-0.35%)
XOM   118.92 (+0.24%)
QQQ   427.60 (+0.41%)
AAPL   168.18 (+0.11%)
MSFT   410.91 (-0.23%)
META   510.58 (+3.32%)
GOOGL   156.18 (+0.46%)
AMZN   182.28 (+0.55%)
TSLA   151.05 (-2.83%)
NVDA   854.23 (+1.65%)
AMD   156.56 (+1.65%)
NIO   4.04 (+3.32%)
BABA   69.52 (+1.02%)
T   16.17 (+0.31%)
F   12.13 (+0.75%)
MU   115.39 (-0.81%)
GE   156.99 (+0.85%)
CGC   7.79 (+20.03%)
DIS   114.00 (+0.94%)
AMC   2.88 (-3.36%)
PFE   25.37 (-0.20%)
PYPL   63.04 (-0.35%)
XOM   118.92 (+0.24%)
QQQ   427.60 (+0.41%)
AAPL   168.18 (+0.11%)
MSFT   410.91 (-0.23%)
META   510.58 (+3.32%)
GOOGL   156.18 (+0.46%)
AMZN   182.28 (+0.55%)
TSLA   151.05 (-2.83%)
NVDA   854.23 (+1.65%)
AMD   156.56 (+1.65%)
NIO   4.04 (+3.32%)
BABA   69.52 (+1.02%)
T   16.17 (+0.31%)
F   12.13 (+0.75%)
MU   115.39 (-0.81%)
GE   156.99 (+0.85%)
CGC   7.79 (+20.03%)
DIS   114.00 (+0.94%)
AMC   2.88 (-3.36%)
PFE   25.37 (-0.20%)
PYPL   63.04 (-0.35%)
XOM   118.92 (+0.24%)
QQQ   427.60 (+0.41%)
AAPL   168.18 (+0.11%)
MSFT   410.91 (-0.23%)
META   510.58 (+3.32%)
GOOGL   156.18 (+0.46%)
AMZN   182.28 (+0.55%)
TSLA   151.05 (-2.83%)
NVDA   854.23 (+1.65%)
AMD   156.56 (+1.65%)
NIO   4.04 (+3.32%)
BABA   69.52 (+1.02%)
T   16.17 (+0.31%)
F   12.13 (+0.75%)
MU   115.39 (-0.81%)
GE   156.99 (+0.85%)
CGC   7.79 (+20.03%)
DIS   114.00 (+0.94%)
AMC   2.88 (-3.36%)
PFE   25.37 (-0.20%)
PYPL   63.04 (-0.35%)
XOM   118.92 (+0.24%)
NASDAQ:BKYI

BIO-key International (BKYI) Stock Price, News & Analysis

$1.67
-0.03 (-1.76%)
(As of 11:01 AM ET)
Today's Range
$1.65
$1.74
50-Day Range
$1.70
$2.22
52-Week Range
$1.50
$15.30
Volume
5,111 shs
Average Volume
133,936 shs
Market Capitalization
$1.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BKYI stock logo

About BIO-key International Stock (NASDAQ:BKYI)

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

BKYI Stock Price History

BKYI Stock News Headlines

BIO-key International Inc
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
BIO-key International, Inc. (BKYI)
BIO-key Intl Stock (NASDAQ:BKYI) Insider Trades
BIO-key International Inc.
See More Headlines
Receive BKYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
4/18/2024
Next Earnings (Estimated)
5/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:BKYI
Employees
51
Year Founded
N/A

Profitability

Net Income
$-11,910,000.00
Pretax Margin
-104.84%

Debt

Sales & Book Value

Annual Sales
$7.02 million
Book Value
$11.28 per share

Miscellaneous

Free Float
658,000
Market Cap
$1.29 million
Optionable
Optionable
Beta
0.41
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

BKYI Stock Analysis - Frequently Asked Questions

How have BKYI shares performed in 2024?

BIO-key International's stock was trading at $3.00 at the start of the year. Since then, BKYI stock has decreased by 41.7% and is now trading at $1.75.
View the best growth stocks for 2024 here
.

Are investors shorting BIO-key International?

BIO-key International saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 18,800 shares, a decline of 8.3% from the March 15th total of 20,500 shares. Based on an average trading volume of 128,500 shares, the short-interest ratio is presently 0.1 days. Currently, 1.2% of the company's shares are sold short.
View BIO-key International's Short Interest
.

When is BIO-key International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 21st 2024.
View our BKYI earnings forecast
.

How were BIO-key International's earnings last quarter?

BIO-key International, Inc. (NASDAQ:BKYI) issued its quarterly earnings results on Monday, November, 15th. The technology company reported ($2.34) earnings per share for the quarter, missing the consensus estimate of ($1.98) by $0.36. The technology company had revenue of $1.30 million for the quarter. BIO-key International had a negative trailing twelve-month return on equity of 136.97% and a negative net margin of 90.82%.

When did BIO-key International's stock split?

BIO-key International shares reverse split on Thursday, December 21st 2023. The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

What guidance has BIO-key International issued on next quarter's earnings?

BIO-key International updated its FY 2023 earnings guidance on Monday, April, 1st. The company provided EPS guidance of -11.450--11.450 for the period. The company issued revenue guidance of $9.1 million-$9.1 million, compared to the consensus revenue estimate of $10.0 million.

What other stocks do shareholders of BIO-key International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BIO-key International investors own include Biocept (BIOC), T2 Biosystems (TTOO), iBio (IBIO), Onconova Therapeutics (ONTX), Acasti Pharma (ACST), Co-Diagnostics (CODX), Heat Biologics (HTBX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV) and Inovio Pharmaceuticals (INO).

How do I buy shares of BIO-key International?

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BKYI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners